A next-generation vaccine that uses a weakened form of a malaria parasite has shown efficacy and safety in a small number of humans, according to a new study published in Science Translational Medicine.
Ujunwa Atueyi
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business